GS:" Expectations for biopharma M&amp;A into the summer months are growing, understandably compounded by $SNY adding 3.firepower by selling its $REGN stake ;which comes on the back of $BMY, $PFE and $MRK all speaking to appetite for deals on recent 1Q earnings calls;...."